Search research articles
Contact Us
Filters
Showing results (151-160 of 397) with videos related to
Page
of 40
Sort By:
Journal of the National Cancer Institute
|
October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Science (New York, N.Y.)
|
May 9, 2015
Human genomics. The human transcriptome across tissues and individuals
Marta Melé, Pedro G Ferreira, Ferran Reverter, et al.
Blood Cancer Discovery
|
September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Livius Penter, Nicoletta Cieri, Katie Maurer, et al.
Cancer Discovery
|
August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
James T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Nature Communications
|
August 12, 2025
A clonally expanded nodal T-cell population diagnosed as T-cell lymphoma after CAR-T therapy
Katie Maurer, Jackson A Weir, Adi Nagler, et al.
Nature Communications
|
December 21, 2017
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Dan A Landau, Clare Sun, Daniel Rosebrock, et al.
Cancer Research
|
September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer
Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Blood Advances
|
August 6, 2024
Inhibition of MICA and MICB shedding enhances memory-like NK-cell-mediated cytotoxicity against multiple myeloma
Sabrin Tahri, Sara Piccinelli, Nang Kham Su, et al.
Nature Communications
|
January 3, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Page
of 40
Search research articles
Search
Showing results (151-160 of 397) with videos related to
Sort By:
Page
of 40
Journal of the National Cancer Institute
|
October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Science (New York, N.Y.)
|
May 9, 2015
Human genomics. The human transcriptome across tissues and individuals
Marta Melé, Pedro G Ferreira, Ferran Reverter, et al.
Blood Cancer Discovery
|
September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Livius Penter, Nicoletta Cieri, Katie Maurer, et al.
Cancer Discovery
|
August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
James T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Nature Communications
|
August 12, 2025
A clonally expanded nodal T-cell population diagnosed as T-cell lymphoma after CAR-T therapy
Katie Maurer, Jackson A Weir, Adi Nagler, et al.
Nature Communications
|
December 21, 2017
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Dan A Landau, Clare Sun, Daniel Rosebrock, et al.
Cancer Research
|
September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer
Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Blood Advances
|
August 6, 2024
Inhibition of MICA and MICB shedding enhances memory-like NK-cell-mediated cytotoxicity against multiple myeloma
Sabrin Tahri, Sara Piccinelli, Nang Kham Su, et al.
Nature Communications
|
January 3, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Page
of 40